Landscapes / Companies

Jiangsu Simcere Pharmaceutical Co., Ltd. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 approved
2 in Phase 3
Next date
SIM0237, Phase 1 trial completes
Drugs
18
in active trials · 28 in all
Trials
21 active
48 since 2021

Drugs18

DrugHow it worksPartnerStageNext dateDetails
Cyclin-dependent kinase inhibitor
Pharmacosmos A/S
Approved 15 Jul 2027Phase 3 trial completes
Unmodified immunoglobulin
Approved in China Jan 2028Phase 3 trial completes
—
Approved in China —
—
Phase 3 31 Aug 2028Phase 3 trial completes
—
Phase 2/3 30 Jun 2029Phase 2/3 trial completes
—
Phase 2 —
—
Phase 1 Jan 2027Phase 1 trial completes
—
Phase 1 30 Jun 2027Phase 1 trial completes
—
Phase 1 Jun 2027Phase 1 trial completes
—
Phase 1 30 Sep 2027Phase 1 trial completes
—
Phase 1 Oct 2027Phase 1 trial completes
—
Phase 1 Dec 2027Phase 1 trial completes
—
Phase 1 Dec 2027Phase 1 trial completes
—
Phase 1 30 Jun 2028Phase 1 trial completes
—
Phase 1 Jun 2028Phase 1 trial completes
—
Phase 1 1 Dec 2028Phase 1 trial completes
—
Phase 1 Dec 2028Phase 1 trial completes
—
Phase 1 Dec 2028Phase 1 trial completes

About

No active trial
10 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Jiangsu Simcere Pharmaceutical Co., Ltd.

Following is part of Solo: you see every change to Jiangsu Simcere Pharmaceutical Co., Ltd. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in